Rehabilitation Intervention to Prevent Adverse Events Related to

Status Recruiting

Clinical Trial Summary

This is a drug-free, single arm, single center, superiority, interventional study aimed at treatment feasibility. The main aim of the current study is to assess feasibility of a tailored exercise program as measured by adherence to exercise program in metastatic PCa patients undergoing ADT. Secondary aims are: to deepen the knowledge on other feasibility aspects (recruitment/retention), to monitor safety, to assess the effects in reducing the AEs of ADT (on loss of strength, loss of physical performance and fatigue, number of accidental falls and fractures), to monitor pain and the change in physical activity habits. The rehabilitation intervention will be led by a Physiotherapist and will include: a 12 weeks standardized multicomponent exercise (aerobic, resistance, balance and flexibility, and impact exercise if indicated), supervised by the physiotherapist, on an outpatient basis or in telerehabilitation. This program will be adapted to single patient needs. Every exercise session will last almost 60 minutes and patients will be supervised twice a week. One more exercise session per week will be self-managed by patients. At baseline a physiatrist will visit patients with bone metastasis and collect data on sites of bone metastasis, associated level of pain, and risk of pathological fractures. For all participants, the physiotherapist will assess muscle strength (Hand Grip Strength-HGS), physical performance (Short Physical Performance Battery-SPPB), level of fatigue (FACIT-F), and data collection on physical activity habits (International Physical Activity Questionnaire-IPAQ). The enrollment will be closed after 1 year from the activation of the study or when the target of patients will be reached, whichever occurs firstly. For each patient, data will be collected for 12 months. The duration of the study is expected to be around 2 years. Follow-ups are scheduled at 12 weeks, 24 weeks and 12 months.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06238596
Study type	Interventional
Source	Azienda Unità Sanitaria Locale Reggio Emilia
Contact
Status	Recruiting
Phase	N/A
Start date	September 6, 2023
Completion date	September 6, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04458480` - Effect of Fast Inpatient Rehabilitation After TKA
Recruiting	`NCT05547152` - Evaluation of the Effectiveness of Virtual Reality Self-rehabilitation in the Treatment of Facial Paralysis and Synkinesis	N/A
Active, not recruiting	`NCT05520528` - Impact of Group Participation on Adults With Aphasia	N/A
Completed	`NCT03661944` - Functional Performance Assessments in Overhead Athletes With Shoulder Injury
Completed	`NCT05875480` - The Effectiveness of Telerehabilitation After Arthroscopic Meniscus Repair	N/A
Not yet recruiting	`NCT05854056` - Tibial Tubercle Distalisation and Accelerated Rehabilitation	N/A
Not yet recruiting	`NCT05177380` - Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis	N/A
Not yet recruiting	`NCT04419753` - The Role of Attention Focus Walking Training in Older Adults.	N/A
Not yet recruiting	`NCT03628495` - Effectiveness of a Combined Pressure and Silicone Intervention for Hypertrophic Scar Treatment	N/A
Completed	`NCT02413996` - Effects of Virtual Reality Rehabilitation in Patients With Total Knee Arthroplasty	N/A
Completed	`NCT01205542` - Work Place Adjusted Intelligent Physical Exercise Reducing Musculoskeletal Pain in Shoulder and Neck (VIMS) - Shoulder Function	N/A
Completed	`NCT02644096` - Rehabilitation of Patients After THR - Based on Patients´Selfrated Health	Phase 1
Completed	`NCT03582371` - Aqua Stand-Up Paddle Balance Effect in Parkinson's Disease (AquaSUP PARK)	N/A
Completed	`NCT05655039` - The Effect of Pre-rehabilitation and Rehabilitation Period on Functional Status in Inpatient Stroke Patients
Completed	`NCT04502654` - Rehabilitation for Thoracoscopic Lobectomy
Enrolling by invitation	`NCT06206018` - Patient-Reported Outcome Measures in Lower Extremity Rehabilitation Program PROM_R: Impact on Health Care	N/A
Completed	`NCT03386604` - Physical Capacity of Patients With Chronic Obstructive Pulmonary Disease With and Without Supplementation of Whey	N/A
Recruiting	`NCT05619666` - Acute Rehabilitation in Patients With COVID-19 Pneumonia	N/A
Completed	`NCT06251791` - Inspiratory Muscle Training and Expiratory Muscle Thickness	N/A
Recruiting	`NCT04626934` - Cognitive Intervention and Rehabilitation Outcomes in Hip Fracture Patients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Rehabilitation Intervention to Prevent Adverse Events Related to Androgen-deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer (PCa): a Single Arm Feasibility Study (ReCaP Study) — ReCaP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms